Transcriptomic profiling of medial temporal lobe epilepsy

Journal of Proteomics and Bioinformatics

Volumn 5, Issue 2, 2012, Pages 31-39

  Venugopal, Abhilash K ^a,b,c   Sameer Kumar, Ghantasala S ^a,b   Mahadevan, Anita ^d   Selvan, Lakshmi Dhevi N ^a,e   Marimuthu, Arivusudar ^a,f   Dikshit, Jyoti Bajpai ^g   Tata, Pramila ^g   Ramachandra, Y L ^b   Chaerkady, Raghothama ^a,b,c   Sinha, Sanjib ^d   Chandramouli, B A ^d   Arivazhagan, A ^d   Satishchandra, Parthasarathy ^d   Shankar, S K ^a   Pandey, Akhilesh ^c  

^a Institute of Bioinformatics   (India)

^b KUVEMPU UNIVERSITY   (India)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

^e AMRITA UNIVERSITY   (India)

^f MANIPAL UNIVERSITY   (India)

^g Strand Life Sciences ^*  (India)

Author keywords

DNA microarrays; GABA receptor; GeneSpring; Medial temporal sclerosis; Temporal lobe epilepsy; Transcriptome profile

Indexed keywords

ADAM METALLOPEPTIDASE WITH THROMBOSPONDIN TYPE 1 MOTIF 15; BONE MORPHOGENETIC PROTEIN RECEPTOR 1B; CLAUDIN 11; METALLOPROTEINASE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DOWN REGULATION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PROGNOSIS; TEMPORAL LOBE EPILEPSY; TRANSCRIPTOMICS; UPREGULATION;

EID: 84858061943     PISSN: None     EISSN: 0974276X     Source Type: Journal    
DOI: 10.4172/jpb.1000210     Document Type: Article

References (47)

1. (2005) Atlas: Epilepsy Care in the World. World Health Organization.
2. Kwan P, Brodie MJ (2000) Early identification of refractory epilepsy. N Engl J Med 342: 314-319.
3. Schmidt D (1982) Two antiepileptic drugs for intractable epilepsy with complexpartial seizures. J Neurol Neurosurg Psychiatry 45: 1119-1124.
4. Brodie MJ, Dichter MA (1996) Antiepileptic drugs. N Engl J Med 334: 168-175.
5. Williamson PD, French JA, Thadani VM, Kim JH, Novelly RA, et al. (1993) Characteristics of medial temporal lobe epilepsy: II. Interictal and ictal scalp electroencephalography, neuropsychological testing, neuroimaging, surgical results, and pathology. Ann Neurol 34: 781-787.
6. Blumcke I, Beck H, Lie AA, Wiestler OD (1999) Molecular neuropathology of human mesial temporal lobe epilepsy. Epilepsy Res 36: 205-223.
7. Becker AJ, Chen J, Paus S, Normann S, Beck H, et al. (2002) Transcriptional profiling in human epilepsy: expression array and single cell real-time qRT-PCR analysis reveal distinct cellular gene regulation. Neuroreport 13: 1327-1333.
8. Arion D, Sabatini M, Unger T, Pastor J, Alonso-Nanclares L, et al. (2006) Correlation of transcriptome profile with electrical activity in temporal lobe epilepsy. Neurobiol Dis 22: 374-387.
9. Xiao Z, Gong Y, Wang XF, Xiao F, Xi ZQ, et al. (2009) Altered expression of synaptotagmin I in temporal lobe tissue of patients with refractory epilepsy. J Mol Neurosci 38: 193-200.
10. Jamali S, Bartolomei F, Robaglia-Schlupp A, Massacrier A, Peragut JC, et al. (2006) Large-scale expression study of human mesial temporal lobe epilepsy: evidence for dysregulation of the neurotransmission and complement systems in the entorhinal cortex. Brain 129: 625-641.
11. van Gassen KL, de Wit M, Koerkamp MJ, Rensen MG, van Rijen PC, et al. (2008) Possible role of the innate immunity in temporal lobe epilepsy. Epilepsia 49: 1055-1065.
12. Lee TS, Mane S, Eid T, Zhao H, Lin A, et al. (2007) Gene expression in temporal lobe epilepsy is consistent with increased release of glutamate by astrocytes. Mol Med 13: 1-13.
13. Lauren HB, Lopez-Picon FR, Brandt AM, Rios-Rojas CJ, Holopainen IE (2010) Transcriptome analysis of the hippocampal CA1 pyramidal cell region after kainic acid-induced status epilepticus in juvenile rats. PLoS One 5: e10733.
14. Mirza N, Vasieva O, Marson AG, Pirmohamed M (2011) Exploring the genomic basis of pharmacoresistance in epilepsy: an integrative analysis of large-scale gene expression profiling studies on brain tissue from epilepsy surgery. Hum Mol Genet 20: 4381-4394.
15. Kashyap MK, Marimuthu A, Kishore CJ, Peri S, Keerthikumar S, et al. (2009) Genomewide mRNA profiling of esophageal squamous cell carcinoma for identification of cancer biomarkers. Cancer Biol Ther 8: 36-46.
16. Kim HS, Yim SV, Jung KH, Zheng LT, Kim YH, et al. (2007) Altered DNA copy number in patients with different seizure disorder type: by array-CGH. Brain Dev 29: 639-643.
17. Ianzano L, Zhao XC, Minassian BA, Scherer SW (2003) Identification of a novel protein interacting with laforin, the EPM2a progressive myoclonus epilepsy gene product. Genomics 81: 579-587.
18. Shim KS, Rosner M, Freilinger A, Lubec G, Hengstschlager M (2006) Bach2 is involved in neuronal differentiation of N1E-115 neuroblastoma cells. Exp Cell Res 312: 2264-2278.
19. Quick Q, Skalli O (2010) Alpha-actinin 1 and alpha-actinin 4: contrasting roles in the survival, motility, and RhoA signaling of astrocytoma cells. Exp Cell Res 316: 1137-1147.
20. Choi YS, Lin SL, Lee B, Kurup P, Cho HY, et al. (2007) Status epilepticusinduced somatostatinergic hilar interneuron degeneration is regulated by striatal enriched protein tyrosine phosphatase. J Neurosci 27: 2999-3009.
21. Braithwaite SP, Xu J, Leung J, Urfer R, Nikolich K, et al. (2008) Expression and function of striatal enriched protein tyrosine phosphatase is profoundly altered in cerebral ischemia. Eur J Neurosci 27: 2444-2452.
22. Poddar R, Deb I, Mukherjee S, Paul S (2010) NR2B-NMDA receptor mediated modulation of the tyrosine phosphatase STEP regulates glutamate induced neuronal cell death. J Neurochem 115: 1350-1362.
23. Shinoda S, Skradski SL, Araki T, Schindler CK, Meller R, et al. (2003) Formation of a tumour necrosis factor receptor 1 molecular scaffolding complex and activation of apoptosis signal-regulating kinase 1 during seizure-induced neuronal death. Eur J Neurosci 17: 2065-2076.
24. Morita K, Saitoh M, Tobiume K, Matsuura H, Enomoto S, et al. (2001) Negative feedback regulation of ASK1 by protein phosphatase 5 (PP5) in response to oxidative stress. EMBO J 20: 6028-6036.
25. Viloria CG, Obaya AJ, Moncada-Pazos A, Llamazares M, Astudillo A, et al. (2009) Genetic inactivation of ADAMTS15 metalloprotease in human colorectal cancer. Cancer Res 69: 4926-4934.
26. Samanta J, Burke GM, McGuire T, Pisarek AJ, Mukhopadhyay A, et al. (2007) BMPR1a signaling determines numbers of oligodendrocytes and calbindinexpressing interneurons in the cortex. J Neurosci 27: 7397-7407.
27. Samanta J, Kessler JA (2004) Interactions between ID and OLIG proteins mediate the inhibitory effects of BMP4 on oligodendroglial differentiation. Development 131: 4131-4142.
28. Sahni V, Mukhopadhyay A, Tysseling V, Hebert A, Birch D, et al. (2010) BMPR1a and BMPR1b signaling exert opposing effects on gliosis after spinal cord injury. J Neurosci 30: 1839-1855.
29. Bronstein JM, Tiwari-Woodruff S, Buznikov AG, Stevens DB (2000) Involvement of OSP/claudin- 11 in oligodendrocyte membrane interactions: role in biology and disease. J Neurosci Res 59: 706-711.
30. Aslam M, Kalluri SR, Cepok S, Kraus V, Buck D, et al. (2010) The antibody response to oligodendrocyte specific protein in multiple sclerosis. J Neuroimmunol 221: 81-86.
31. Rimondini R, O'Connor WT, Sillard R, Mutt V, Ungerstedt U, et al. (1996) The secretory trypsin inhibitor like-peptide, PEC-60 increases dopamine D2 receptor agonist induced inhibition of GABA release in the dorsolateral neostriatum of the awake freely moving rat. An in vivo microdialysis study. Regul Pept 61: 111-117.
32. Schlingmann KP, Weber S, Peters M, Niemann Nejsum L, Vitzthum H, et al. (2002) Hypomagnesemia with secondary hypocalcemia is caused by mutations in TRPM6, a new member of the TRPM gene family. Nat Genet 31: 166-170.
33. Jiang SP, Wu YM, Guo SE, Lv ZQ (2010) Decreased renal mRNA expression of TRPM6 is associated with hypomagnesemia in C57BL/6 asthmatic mice. Eur Rev Med Pharmacol Sci 14: 935-940.
34. Bagdy G, Kecskemeti V, Riba P, Jakus R (2007) Serotonin and epilepsy. J Neurochem 100: 857-873.
35. Aronica E, Gorter JA (2007) Gene expression profile in temporal lobe epilepsy. Neuroscientist 13: 100-108.
36. Tashiro A, Goldberg J, Yuste R (2002) Calcium oscillations in neocortical astrocytes under epileptiform conditions. J Neurobiol 50: 45-55.
37. Amzica F, Massimini M, Manfridi A (2002) Spatial buffering during slow and paroxysmal sleep oscillations in cortical networks of glial cells in vivo. J Neurosci 22: 1042-1053.
38. Kendal C, Everall I, Polkey C, Al-Sarraj S (1999) Glial cell changes in the white matter in temporal lobe epilepsy. Epilepsy Res 36: 43-51.
39. Carrero-Valenzuela RD, Quan F, Lightowlers R, Kennaway NG, Litt M, et al. (1991) Human cytochrome c oxidase subunit VIb: characterization and mapping of a multigene family. Gene 102: 229-236.
40. Geneslaw AS, Zhao M, Ma H, Schwartz TH (2011) Tissue hypoxia correlates with intensity of interictal spikes. J Cereb Blood Flow Metab 31: 1394-1402.
41. Stevens SL, Shaw TE, Dykhuizen E, Lessov NS, Hill JK, et al. (2003) Reduced cerebral injury in CRH-R1 deficient mice after focal ischemia: a potential link to microglia and atrocytes that express CRH-R1. J Cereb Blood Flow Metab 23: 1151-1159.
42. Knopp A, Frahm C, Fidzinski P, Witte OW, Behr J (2008) Loss of GABAergic neurons in the subiculum and its functional implications in temporal lobe epilepsy. Brain 131: 1516-1527.
43. Kim YS, Choi MY, Kim YH, Jeon BT, Lee DH, et al. (2010) Protein kinase Cdelta is associated with 14-3-3 phosphorylation in seizure-induced neuronal death. Epilepsy Res 92: 30-40.
44. Boison D (2006) Adenosine kinase, epilepsy and stroke: mechanisms and therapies. Trends Pharmacol Sci 27: 652-658.
45. Gajda Z, Torok R, Horvath Z, Szantai-Kis C, Orfi L, et al. (2011) Protein kinase inhibitor as a potential candidate for epilepsy treatment. Epilepsia 52: 579-588.
46. Kazantseva A, Sepp M, Kazantseva J, Sadam H, Pruunsild P, et al. (2009) N-terminally truncated BAF57 isoforms contribute to the diversity of SWI/SNF complexes in neurons. J Neurochem 109: 807-818.
47. Alessio N, Squillaro T, Cipollaro M, Bagella L, Giordano A, et al. (2010) The BRG1 ATPase of chromatin remodeling complexes is involved in modulation of mesenchymal stem cell senescence through RB-P53 pathways. Oncogene 29: 5452-5463.